ghk cu topical vs. injectable GHK-Cu Dosing: 1.7mg/Day (2026) GHK-Cu Topical vs Injectable: 10x
Description
Favorable Safety and Tolerability Profile : Across available studies, AOD-9604 has shown a favorable safety profile with no significant adverse hormonal or metabolic effects observed at experimental doses
Tendons and ligaments have limited blood supply compared to muscle
Its most-researched applications in preclinical models include gastric ulcer healing, inflammatory bowel disease, leaky gut, and intestinal repair
That role is real and well described in biochemistry
